Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Everett Meyer

T-cell monitoring and immunotherapy for treating graft-versus-host disease

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Investigator from Dana–Farber Cancer Institute

Nursing Oncology Capacity Building through Fellowship Programs in Rwanda and Haiti

Non-Hodgkin lymphoma

Charles Wood

Fogarty International Training Program in HIV- and AIDS-Associated Malignancies

Non-Hodgkin lymphoma

Wilburn E. Reddick

ALL therapy and developing brains: MRI measures, genetic factors and cognition

Leukaemia

Pediatric oncology or childhood cancer

Eduardo M. Sotomayor

Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy

Hodgkin lymphoma Non-Hodgkin lymphoma

Andrew G Myers

Synthesis and Study of Natural and Non-natural Antiproliferative Agents

Leukaemia

Hematology and hematologic malignancies Pathology

Corey Casper

Uganda Cancer Institute / Hutchinson Center Cancer Alliance (UCI/HCCA)

Hodgkin lymphoma Non-Hodgkin lymphoma

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies